Skip to content

APEMESH- Preventing Perineal Complications After Abdominoperineal Resection

APEMESH- Preventing Perineal Complications After Abdominoperineal Resection

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04334421
Enrollment
30
Registered
2020-04-06
Start date
2020-04-03
Completion date
2022-02-28
Last updated
2024-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominoperineal Resection, Rectal Cancer, Wound Heal

Brief summary

Abdominoperineal resection leaves an empty space to be filled by mesh or musculocutaneus flap. Several studies have reported over 30% morbidity with perineal wound healing after abdominoperineal resection. Preoperative radiotherapy is a strong predictor for perineal complications. Musculocutaneus flaps and use of biological mesh seem to minimize perineal morbidity. The role of omentoplasty at APR is controversial. Previous studies on synthetic mesh repair on perineum are almost lacking.

Detailed description

The objective of this pilot study is to assess the feasibility and the potential benefits of synthetic mesh reconstruction in perineum in case-control setting. 30 subjects will be prospectively enrolled to this study as intervention group. Controls matched with age, gender and preoperative radiotherapy are selected from retrospective data collected from Oulu University database and operated for rectal adenocarcinoma 2009-2017 with otherwise identical methods.

Interventions

DEVICEComposite mesh

Pelvic floor is reconstructed by synthetic composite mesh (Symbotex, Medtronic) to improve healing and prevent perineal herniation.

Sponsors

Elisa Mäkäräinen
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Abdominoperineal resection and permanent colostoma

Exclusion criteria

* Patient with a comorbid illness of condition that would preclude the use of surgery (ASA5) * Potentially curable resection not possible * Patient undergoing emergency procedure * Metastatic disease * Pregnant or suspected pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Comprehensive Complication index30 daysComprehensive Complication index is used to evaluate outcome

Secondary

MeasureTime frameDescription
Reoperation rate30 daysReoperations during primary stay at the hospital
Operative time30 daysOperative time
Length of stay30 daysLength of stay at the hospital during primary operation and recovery
Surgical site infection30 daysSurgical site infection classified by Clavien-Dindo score
Total perineal healing time30 daysTime to point when perineum is closed and healed
Perineal sinus30 daysPresence of perineal sinus at 30 days follow-up
Perineal hernia12 monthsPerineal hernia by CT scan at 12 months follow-up
Costs30 daysCosts by materials used

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026